Transforming growth factor-β1 gene polymorphism in mycosis fungoides

Clin Exp Dermatol. 2014 Oct;39(7):806-9. doi: 10.1111/ced.12404. Epub 2014 Aug 22.

Abstract

Background: Dysregulation in transforming growth factor (TGF)-β1 signalling pathways has been linked to cancer.

Aim: To study the association between single nucleotide polymorphisms (SNPs) of the TGF-β1 gene and mycosis fungoides (MF).

Methods: Using restriction fragment length polymorphism analysis, SNPs in the TGF-β1 gene were studied in 55 patients with MF of different stages and in 100 apparently healthy controls.

Results: A significant difference was found between patients and controls in distribution of the different TGF-β1 genotypes, with mutant forms (T/C, T/T) encountered significantly more often in patients with MF (P < 0.001). The heterozygous genotype (T/C) was significantly associated with patch stage MF, whereas the homozygous genotype (T/T) was significantly associated with tumour stage (stage IIb) MF (P = 0.001), although this study included only a small number of these patients.

Conclusions: Mutant TGF-β1 genotypes are significantly associated with MF in Egyptian patients, with the homozygous genotype (T/T) having a stronger association with tumour stage (stage IIb).

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Case-Control Studies
  • Egypt
  • Female
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Mycosis Fungoides / genetics*
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single Nucleotide*
  • Skin Neoplasms / genetics*
  • Transforming Growth Factor beta1 / genetics*
  • Young Adult

Substances

  • Transforming Growth Factor beta1